About Converge Biotech
Converge Biotech is a company based in Hyderabad (India) founded in 2014. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. The company has 183 employees as of March 29, 2025. Converge Biotech offers products and services including Branded Formulations and Enzewhey 98.
- Headquarter Hyderabad, India
- Employees 183 as on 29 Mar, 2025
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Converge Biotech Pvt Ltd
- Date of Incorporation 26 Aug, 2014
- Jurisdiction Ameerpet, Telangana, India
-
Annual Revenue
$7.09 M (USD)-6.41as on Mar 31, 2024
-
Net Profit
$294.98 K (USD)489.09as on Mar 31, 2024
-
EBITDA
$547.23 K (USD)276.54as on Mar 31, 2024
-
Latest Funding Round
$897.91 K (USD), Grant
Sep 27, 2014
- Investors
-
Employee Count
183
as on Mar 29, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Converge Biotech
Converge Biotech offers a comprehensive portfolio of products and services, including Branded Formulations and Enzewhey 98.
Branded formulations are developed for chronic care sectors.
Enzewhey 98 is provided for critically ill patients.
People of Converge Biotech
Unlock access to complete
Funding Insights of Converge Biotech
Investors in Converge Biotech
Converge Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Converge Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Converge Biotech
Investment portfolio details for Converge Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Converge Biotech
Detailed financials for Converge Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Converge Biotech Comparisons
Peer comparison for Converge Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Converge Biotech
Detailed competitors of Converge Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Converge Biotech
Complete news archive for Converge Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Converge Biotech
Converge Biotech was founded in 2014.
Converge Biotech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 29, 2025, the latest employee count at Converge Biotech is 183.
Annual revenue of Converge Biotech is $7.09M as on Mar 31, 2024.
Converge Biotech, based in Hyderabad, India, is focused on the development and distribution of branded pharmaceutical formulations, particularly in the chronic care sector. The company is recognized for making high-quality and affordable medicines accessible to patients globally. Operations are extended into the Indian and international markets, with plans for further overseas expansion. Trust and long-term relationships are built with stakeholders, healthcare providers, and institutions in the global generic market.
Converge Biotech offers Branded Formulations and Enzewhey 98.
Converge Biotech has 1 investor. Key investors include HHS.